Welcome To 2021
We at PSM are happy to wave goodbye to 2020. If you’re a reporter who covers healthcare and especially public health issues, this is what we think you should be watching for in the next six months of a better 2021.
2020 National Drug Threat Assessment
In January, the Drug Enforcement Administration releases their National Drug Threat Assessment, which gathers declassified intelligence, public health data; government reporting and new coverage to provide a clear picture about who’s trafficking in illegal and counterfeit drugs, what techniques they’re using, and where it’s happening.
We’re watching for new details on the Mexican cartels, who have taken over the fake pill industry and infiltrated legal Mexican pharmacies.
February marks the the second anniversary of Pill Presses: An Overlooked Threat to American Patients, a collaboration with NABP and the National Association of Drug Diversion Investigators that examines the significant role of illegal pill presses in the counterfeit pill trade.
Pill presses have continued to flood into the country and we’ll cover new developments in this area of crime.
Congress’ temporary scheduling of Fentanyl expires in May. If Congress allows Schedule I status for fentanyl and fentanyl analogues to lapse, the change could disrupt hundreds of drug trafficking prosecutions.
Finally, we expect new drug importation news in June. That’s when Florida and New Mexico are required to announce the Canadian companies that have agreed to supply medicines for their state importation programs.